Development and FDA Approval The development of Sermorelin arose from research in the 1970s-1980s that characterized GHRH structure, function, and identified that the biologically active portion responsible for GH-releasing activity resides in the N-terminal region of the molecule, specifically amino acids 1-29, while the C-terminal portion (amino acids 30-44) is not required for receptor binding or signaling
Studies of carnitine supplements in middle-aged adults living with type 2 diabetes have generated mixed results
For individuals on cyclosporine or levothyroxine, it is important to time these medications to avoid interference with orlistat
Liposomal glutathione can power up your bodys antioxidants and recharge them, as well as remove harmful compounds and toxic substances in your body
Evaluation of female FertilityAMH and ovarian reserve testing
Collagen support: improves tone, elasticity & skin tightening post-weight loss